Detalles de la búsqueda
1.
Observational outcomes in proliferative diabetic retinopathy patients following treatment with ranibizumab, panretinal laser photocoagulation or combination therapy - The non-interventional second year follow-up to the PRIDE study.
Acta Ophthalmol
; 100(2): e578-e587, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34121335
2.
Reporting of Safety Events during Anti-VEGF Treatment: Pharmacovigilance in a Noninterventional Trial.
J Ophthalmol
; 2020: 8652370, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33083052
3.
Efficacy and safety of ranibizumab with or without panretinal laser photocoagulation versus laser photocoagulation alone in proliferative diabetic retinopathy - the PRIDE study.
Acta Ophthalmol
; 98(5): e530-e539, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31808278
4.
ORCA study: real-world versus reading centre assessment of disease activity of neovascular age-related macular degeneration (nAMD).
Br J Ophthalmol
; 104(11): 1573-1578, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32066561
5.
Intravitreal Ranibizumab Therapy for Diabetic Macular Edema in Routine Practice: Two-Year Real-Life Data from a Non-interventional, Multicenter Study in Germany.
Diabetes Ther
; 9(6): 2271-2289, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30288700
Resultados
1 -
5
de 5
1
Próxima >
>>